Nitrendipine tablets Irbesartan combined treatment of 50 hypertensive patients of clinical experience.doc

 PAGE \* MERGEFORMAT 7 Nitrendipine tablets Irbesartan combined treatment of 50 hypertensive patients of clinical experience [Abstract] Objective nitrendipine combined irbesartan tablet in the treatment of hypertension patients. Methods in November 2006 ~ October 2009 the author treated with irbesartan tablets plus nitrendipine .1 50 cases of patients with hypertension Clinical data of patients are in line with 1999 WHO diagnostic criteria developed hypertension, 29 males and 21 females, average duration of treatment 5-22 years .2: 6 am and were at 4 pm oral nitrendipine 10mg, morning 6 oral irbesartan tablets 75mg, recording blood pressure, testing before and after treatment of left ventricular diastolic function changes. Blood pressure measured by cuff mercury sphygmomanometer, taking the right arm sitting blood pressure measurements, blood pressure measurement before the sat and rested 10min. effect markedly evaluation criteria: diastolic blood pressure decreased after treatmentgt; = 10mmHg, and 20mmHg decrease to normal or above. effective: After treatment, does not exceed 10mmHg diastolic blood pressure decreased, but has dropped to normal range, or down 10 ~ 19mmHg; such as systolic hypertension, systolic blood pressure decreasegt; = 30mmHg. invalid: After treatment, blood pressure did not achieve an effective standard. Results markedly effective in 20 cases, 40%, effective in 26 cases, 52%, 4 cases, accounting for 8% of the total effective rate was 92 %. Conclusions November 2006 ~ October 2009 United irbesartan tablets by nitrendipine treatment of hypertension in 50 cases, satisfactory effect can reduce the incidence of complications of hypertension, to avoid cardiovascular and cerebrovascular accident, improve the quality of life, so the United nitrendipine tablets Irbesartan treatment of hypertension is one of the ideal. [Keywords:] nitrendipine in essential hypertension irbesartan tablets Hypertension is the most common cardiovascular d